BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7393237)

  • 1. Solvent perturbation of the fluorescence of fluorescyl ligand bound to specific antibody. Fluorescence enhancement of antibody bound fluorescein (hapten) in deuterium oxide.
    Voss EW; Watt RM; Weber G
    Mol Immunol; 1980 Apr; 17(4):505-17. PubMed ID: 7393237
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of ligand binding by monoclonal anti-fluorescyl antibodies.
    Kranz DM; Herron JN; Voss EW
    J Biol Chem; 1982 Jun; 257(12):6987-95. PubMed ID: 6806261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen valence and Fc-localized secondary forces in antibody precipitation.
    Rodwell JD; Lih-Heng-Tang ; Schumaker VN
    Mol Immunol; 1980 Dec; 17(12):1591-7. PubMed ID: 6170880
    [No Abstract]   [Full Text] [Related]  

  • 4. 4-4-20 anti-fluorescyl IgG Fab' recognition of membrane bound hapten: direct evidence for the role of protein and interfacial structure.
    Leckband DE; Kuhl T; Wang HK; Herron J; Müller W; Ringsdorf H
    Biochemistry; 1995 Sep; 34(36):11467-78. PubMed ID: 7547875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equilibrium and kinetic parameters for the interaction of a monoclonal antibody with liposomes bearing fluorescent haptens.
    Petrossian A
    Cell Biophys; 1993; 23(1-3):111-37. PubMed ID: 7895247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrete bathochromic shifts exhibited by fluorescein ligand bound to rabbit polyclonal anti-fluorescein Fab fragments.
    Voss EW; Croney JC; Jameson DM
    J Protein Chem; 2002 May; 21(4):231-41. PubMed ID: 12168694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and mechanism of deuterium oxide-induced fluorescence enhancement of fluorescyl ligand bound to specific heterogeneous and homogeneous antibodies.
    Kranz DM; Herron JN; Giannis DE; Voss EW
    J Biol Chem; 1981 May; 256(9):4433-8. PubMed ID: 7217089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal antibodies specific for liganded active site (metatype) of a high affinity anti-hapten monoclonal antibody.
    Voss EW; Miklasz SD; Petrossian A; Dombrink-Kurtzman MA
    Mol Immunol; 1988 Aug; 25(8):751-9. PubMed ID: 3185570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solvent perturbation of the fluorescence of fluorescein bound to specific antibody. Fluorescence quenching of the bound fluorophore by iodide.
    Watt RM; Voss EW
    J Biol Chem; 1979 Mar; 254(5):1684-90. PubMed ID: 570194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of IgE-receptor complexes at the cell surface: a fluorescence method for studying the binding of monovalent and bivalent haptens to IgE.
    Erickson J; Kane P; Goldstein B; Holowka D; Baird B
    Mol Immunol; 1986 Jul; 23(7):769-81. PubMed ID: 2948110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of antibodies with liposomes bearing fluorescent haptens.
    Petrossian A; Owicki JC
    Biochim Biophys Acta; 1984 Oct; 776(2):217-27. PubMed ID: 6477908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the evolution of an antibody combining site.
    Wedemayer GJ; Patten PA; Wang LH; Schultz PG; Stevens RC
    Science; 1997 Jun; 276(5319):1665-9. PubMed ID: 9180069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoprecipitation properties of a high-affinity monoclonal IgM anti-fluorescyl antibody.
    Dombrink-Kurtzman MA; Voss EW
    Mol Immunol; 1988 Dec; 25(12):1309-20. PubMed ID: 3237215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of heterogeneous dissociation kinetics in polyclonal populations of rabbit anti-fluorescyl-IgG antibodies.
    Herron JN; Voss EW
    Mol Immunol; 1983 Dec; 20(12):1323-32. PubMed ID: 6656777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular stabilization effects of interactions between anti-metatype antibodies and liganded antibody.
    Weidner KM; Denzin LK; Voss EW
    J Biol Chem; 1992 May; 267(15):10281-8. PubMed ID: 1587817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand binding to anti-fluorescyl antibodies: stability of the antigen binding site.
    Müller JD; Nienhaus GU; Tetin SY; Voss EW
    Biochemistry; 1994 May; 33(20):6221-7. PubMed ID: 8193136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial elucidation of an anti-hapten repertoire in BALB/c mice: comparative characterization of several monoclonal anti-fluorescyl antibodies.
    Kranz DM; Voss EW
    Mol Immunol; 1981 Oct; 18(10):889-98. PubMed ID: 7335083
    [No Abstract]   [Full Text] [Related]  

  • 18. Flexible structure of immunoglobulin G molecule. Fluorescence depolarization studies on hapten-antihapten antibody interactions using arylnaphthalenesulfonates as the ligands.
    Murakami K; Nakamura H
    Jpn J Exp Med; 1976 Feb; 46(1):59-70. PubMed ID: 945389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of affinity-labeled fluorescyl ligand to specifically-purified rabbit IgG antibodies.
    Watt RM; Voss EW
    Immunochemistry; 1978 Dec; 15(12):875-82. PubMed ID: 750368
    [No Abstract]   [Full Text] [Related]  

  • 20. The three dimensional structure of a combining region-ligand complex of immunoglobulin NEW at 3.5-A resolution.
    Amzel LM; Poljak RJ; Saul F; Varga JM; Richards FF
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1427-30. PubMed ID: 4524646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.